Cyclacel Pharmaceuticals (CYCC) shoots up 11.5% in premarket trading after the firm reports...

|About: Cyclacel Pharmaceuticals,... (CYCC)|By:, SA News Editor

Cyclacel Pharmaceuticals (CYCC) shoots up 11.5% in premarket trading after the firm reports positive results for its Sapacitabine drug in a phase 2 trial on MDS patients.